An experimental drug called mepolizumab can prevent severe asthma attacks in people with an uncommon form of the disease that responds poorly to standard steroid medications, researchers report in two studies in the March 5 New England Journal of Medicine.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.